Shuen-Iu Hung

Title: **Innovative Contributions of Inventor Shuen-Iu Hung**

Introduction

Inventor Shuen-Iu Hung, based in Chang-Hwa, Taiwan, has made significant strides in the field of drug safety through his innovative methods and inventions. With a total of nine patents to his name, Hung has focused his research on predicting adverse drug reactions, particularly related to phenytoin. His work has the potential to greatly enhance patient safety and the effectiveness of drug therapies.

Latest Patents

Shuen-Iu Hung holds several important patents, including methods for risk assessment in relation to phenytoin-induced adverse drug reactions. One of his latest patents discloses a method for predicting a patient's risk of developing serious conditions such as Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), or drug reactions with eosinophilia and systemic symptoms (DRESS) due to phenytoin or fosphenytoin use. This invention leverages genetic polymorphisms of CYP2C genes and HLA alleles to assess risks, providing a test kit to evaluate these risks based on the presence of certain alleles.

Another notable patent from Hung involves a method for identifying HLA complexes associated with adverse drug reactions. This invention allows for the assessment of whether a compound may induce adverse drug reactions and helps in understanding which human populations may be at risk, significantly impacting the field of pharmacogenomics.

Career Highlights

Shuen-Iu Hung has built a remarkable career, contributing to key advancements in drug safety and therapeutics. His work has been conducted at prestigious institutions such as Academia Sinica and the Chang Gung Medical Foundation, Linkou Branch. These affiliations have provided him with a robust platform to further his research and innovation in the medical field.

Collaborations

Throughout his career, Hung has collaborated with other notable researchers, including Yuan-Tsong Chen and Wen-hung Chung. These collaborations have fostered the exchange of ideas and expertise, enhancing the quality and impact of his work in addressing critical issues related to adverse drug reactions.

Conclusion

Shuen-Iu Hung's innovative contributions to the field of drug safety are both impactful and essential. Through his research and patents, he has provided valuable methods for predicting adverse reactions associated with phenytoin and improving patient safety. His ongoing work continues to shape the future of pharmacotherapy and reflects the importance of innovation in the medical industry.